These facts are updated till 22 Dec 2023, and are based on Volza's India Import dataIndia Import data of Lopinavir sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
30049099 | TABLETS >> TABLETS BOTTLE LOPINAVIR-RITONAVIR ALUVIA , 200-50MG TABLETS, 120 TABLETS-BOTTLE IMP T. LIC NO. 137-CT-BE-13 DT. 04.10.2013 FOR CLIN | Germany | India | 50 | |||
30049099 | TABLETS >> KALETRA-ALUVIA LOPINAVIR 200MG + RETINOVIR-50MG TABLETS , 6 BOTTLE X 120'S = 720 TABLETS | United Kingdom | India | 6 | |||
38220090 | REAGENTS >> LOPINAVIR FOR PEAK IDENTIFICATION 10MG LABORATORY REAGENTS - FOR RESEARCH PURPOSE ONLY | France | India | 2 | 60 More Columns Available | ||
29181990 | PHARMACEUTICAL >> EP-Y0001498-LOPINAVIR- 200MG - PHARMACEUTICAL REFERENCE STANDARD 3NOS | France | India | 600 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR LIST NO. 3 , SR.NO.95 | Germany | India | 2687 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR LIST NO. 3 , SR.NO. 95 | Germany | India | 100 | |||
29341000 | RITONAVIR >> RITONAVIR LOPINAVIR SAMPLES OF EXTRUSION TRIALS 200 G OF EXTRUDED MATERIAL CONTAINING , RITONAVIR LOPINAVIR , PLASDONE S-360 , SPAN 20 , AEROSIL200 | Germany | India | 1.50 | |||
30049099 | TABLETS >> ALUVIA-KALETRA LOPINAVIR 200MG + RITONAVIR 50MG TABLETS , 120'S IMP TEST LIC NO:GCT-26 1 TL-15 DT.21.04.2015 & GCT-2 | United States | India | 100 | |||
38220090 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY CRS -Y0001505 LABORATORY R - EAGENTS FOR RESEARCH PURPOSE ONLY | France | India | 3 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - 1NOS | United States | India | 350 | |||
38220090 | LABORAT >> Y0001498 LOPINAVIR CRS 200MG REFERENCE STANDARD FOR LABORAT - ORY USE ONLY | France | India | 1 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - | United States | India | 1 | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG - 2NOS | France | India | 400 | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG - 3NOS | France | India | 600 | |||
29339900 | SAMPLE >> TRADE SAMPLE LOPINAVIR F.O.C AS FREE TRADE SAMPLE FORDEVELOPMENT PURPOSE | China | India | 15 | |||
38220019 | REAGENT >> LOPINAVIR FOR PEAK IDENTIFICATION CRS LABORATORY REAGENT FO - R R&D PURPOSE ONLY | France | India | 2 | |||
30049099 | TABLETS >> KALETRA- LOPINAVIR AND RITONAVIR SOLUTION 200MG-50MG TABLETS - PACK SIZE: 120 TABS TESTING PURPOSE ONLY | United States | India | 5 | |||
38220090 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - USP REFERENCE STANDARD - S FOR LABORATORY USE | United States | India | 2 | |||
38220090 | LOPINAVIR >> Lopinavir 0.6 g | United States | India | 1 | |||
29339900 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY 1 NO X 10 MG | France | India | 0.00 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
30049099 | SOLUTION >> ORAL SOLUTION KALETRA LOPINAVIR-RITONAVIR ORAL SOLUTION 80-20MG-ML QTY: 9 BTL | United States | India | 0.00 | |||
29339900 | LOPINAVIR >> LOPINAVIR | China | India | 15 | |||
29339900 | ORGANIC >> ORGANIC CHEMICAL SML1222-10MG LOPINAVIR [ORGANIC CHEMICAL] | United States | India | 2 | |||
29333990 | CHEMICAL >> ORGANIC CHEMICAL SML1222-50MG LOPINAVIR [ORGANIC CHEMICAL] | Germany | India | 1 | |||
29339900 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR SYSTEM SUITABILITY MIXTURE 20 MG -N | United States | India | NA | |||
38220090 | SYSTEM >> SYSTEM SUITABILITY Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS- 10MG PER VAIL 2 VAIL REFERENCE STANDARD FOR LABORATORY USE ONLY | France | India | NA | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG | France | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 6 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR 350 MG | United States | India | 1 | |||
38220090 | PHARMACEUTICAL >> PHARMACEUTICAL REFERENCE STANDARD - Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS 10 MG | France | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 4 | |||
29339900 | CHEMICAL >> ORGANIC CHEMICAL SML1222-50MG LOPINAVIR [ORGANIC CHEMICAL] | Germany | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
30049099 | HDPE >> KALETRA LOPINAVIR - RITONAVIR 200-50 MG TAB [HDPE-120]-ABBVIE | United States | India | 2 | |||
29335990 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY 3 NOS X 10 MG | France | India | 0.01 | |||
29335990 | PEAK >> LOPINAVIR FOR PEAK IDENTIFICATION 3 NOS X 10 MG | France | India | 0.01 | |||
30049099 | SIZE >> KALETRA LOPINAVIR AND RITONAVIR 200-50 MG TAB QTY.1 PACK , PACK SIZE.120S IN 1 BOTTLE | United States | India | 1 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR | Germany | India | 2500 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
30049099 | TABLETS >> KALETRA-LOPINAVIR AND RITONAVIR TABLET 200MG-50MG 8 BOTTLESX 120 TABLETS =960 TABLETS | United States | India | 0.24 | |||
29335990 | GRAMS >> 24761 LOPINAVIR REFERENCE STANDARD FOR VALUE FOR CUSTOM P - URPOSE ONLY 2 GRAMS | United States | India | 1 | |||
30049099 | TABLETS >> RITONAVIR TABLETS LOPINAVIR AND RITONAVIR TABLETS 200MG-50MG KALETRA 1 PACK X120 TABLETS = 120 TABLETS | Germany | India | 0.03 | |||
38229010 | 1370101 LOPINAVIR 350 MGCERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10 MGCERTIFIED REFERENCE STANDARDS | United States | India | 2 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10 MGCERTIFIED REFERENCE STANDARDS | United States | India | 3 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
30049099 | lopinavir and ritonavir tablets 200 mg/50 mg 200/50 milligram mg KALETRA 2 PACKS X 120 TABLETS = 240 TABLETS | United States | India | 0.06 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
29339990 | LOPINAVIR AMORPHOUS USP RE-IMPORT VIDE SB.NO:4000577 DT:02.09.2020, SB NO:4000343 DT:10.06.2020 | Mexico | India | 297 | |||
29335999 | LOPINAVIR. | Mexico | India | 297.12 | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | 7 | |||
30049099 | KALETRA FILM-COATED TABLETS LOPINAVIR AND RITONAVIR FILM-COATED TABLETS 200MG/50MG 4 PACKS X 120 TABLETS =480 TABLETS | Malaysia | India | 0.12 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | 1370101 - LOPINAVIR 350 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
38229010 | 1370101 - LOPINAVIR 350 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370101 LOPINAVIR 350 MG CERTIFIED REFERANCE STANDARDS | United States | India | 2 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 2 | |||
38229010 | Y0001498 - LOPINAVIR CRS-170 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001498 - LOPINAVIR CRS-170 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 1 | |||
38229010 | 1370156 - LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MG//R143T0/EAR90 CERTIFIED REFERENCE STANDARDS | United States | India | 5 | |||
38229010 | 1370101 - LOPINAVIR 350 MG/192725-17-0/R143S0/EAR99 CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 2 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 1 | |||
30049099 | Lopinavir and Ritonavir Tablets 100/25mg Kaletra 60 tablets qty 5 | United States | India | 5 | |||
29339990 | LOPINAVIR 350MG FOR TESTING PURPOSE | Belgium | India | 2 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 1 | |||
30049099 | Lopinavir and Ritonavir Tablets 200/50mg Kaletra 120 tablets qty 3 | United States | India | 3 | |||
38229010 | 1370101 - LOPINAVIR 350 MG/192725-17-0/R143S0/EAR99 CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 - LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MG//R143T0/EAR90 CERTIFIED REFERENCE STANDARDS | United States | India | 5 | |||
30049099 | LOPINAVIR AND RITONAVIR TABLETS 200MG/50MG 200/50 MILLIGRAMMGKALETRA 2 PACKS X 120 TABLETS = 240 TABLETS | United States | India | 0.20 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 1 | |||
98020000 | LOPINAVIR, L0377-1G LABORATORY CHEMICALS FOR R & D PURPOSE | China | India | 1 | |||
30049099 | LOPINAVIR AND RITONAVIR ORAL SOLUTION KALETRA 80/20 MILLIGRAM MG EACH BOTTLE 160 ML 4 BOTTLES | United States | India | 0.01 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
30049099 | TABLETS >> TABLETS BOTTLE LOPINAVIR-RITONAVIR ALUVIA , 200-50MG TABLETS, 120 TABLETS-BOTTLE IMP T. LIC NO. 137-CT-BE-13 DT. 04.10.2013 FOR CLIN | Germany | India | 50 | |||
30049099 | TABLETS >> KALETRA-ALUVIA LOPINAVIR 200MG + RETINOVIR-50MG TABLETS , 6 BOTTLE X 120'S = 720 TABLETS | United Kingdom | India | 6 | |||
38220090 | REAGENTS >> LOPINAVIR FOR PEAK IDENTIFICATION 10MG LABORATORY REAGENTS - FOR RESEARCH PURPOSE ONLY | France | India | 2 | 60 More Columns Available | ||
29181990 | PHARMACEUTICAL >> EP-Y0001498-LOPINAVIR- 200MG - PHARMACEUTICAL REFERENCE STANDARD 3NOS | France | India | 600 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR LIST NO. 3 , SR.NO.95 | Germany | India | 2687 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR LIST NO. 3 , SR.NO. 95 | Germany | India | 100 | |||
29341000 | RITONAVIR >> RITONAVIR LOPINAVIR SAMPLES OF EXTRUSION TRIALS 200 G OF EXTRUDED MATERIAL CONTAINING , RITONAVIR LOPINAVIR , PLASDONE S-360 , SPAN 20 , AEROSIL200 | Germany | India | 1.50 | |||
30049099 | TABLETS >> ALUVIA-KALETRA LOPINAVIR 200MG + RITONAVIR 50MG TABLETS , 120'S IMP TEST LIC NO:GCT-26 1 TL-15 DT.21.04.2015 & GCT-2 | United States | India | 100 | |||
38220090 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY CRS -Y0001505 LABORATORY R - EAGENTS FOR RESEARCH PURPOSE ONLY | France | India | 3 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - 1NOS | United States | India | 350 | |||
38220090 | LABORAT >> Y0001498 LOPINAVIR CRS 200MG REFERENCE STANDARD FOR LABORAT - ORY USE ONLY | France | India | 1 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - | United States | India | 1 | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG - 2NOS | France | India | 400 | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG - 3NOS | France | India | 600 | |||
29339900 | SAMPLE >> TRADE SAMPLE LOPINAVIR F.O.C AS FREE TRADE SAMPLE FORDEVELOPMENT PURPOSE | China | India | 15 | |||
38220019 | REAGENT >> LOPINAVIR FOR PEAK IDENTIFICATION CRS LABORATORY REAGENT FO - R R&D PURPOSE ONLY | France | India | 2 | |||
30049099 | TABLETS >> KALETRA- LOPINAVIR AND RITONAVIR SOLUTION 200MG-50MG TABLETS - PACK SIZE: 120 TABS TESTING PURPOSE ONLY | United States | India | 5 | |||
38220090 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG - USP REFERENCE STANDARD - S FOR LABORATORY USE | United States | India | 2 | |||
38220090 | LOPINAVIR >> Lopinavir 0.6 g | United States | India | 1 | |||
29339900 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY 1 NO X 10 MG | France | India | 0.00 | |||
29339900 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
30049099 | SOLUTION >> ORAL SOLUTION KALETRA LOPINAVIR-RITONAVIR ORAL SOLUTION 80-20MG-ML QTY: 9 BTL | United States | India | 0.00 | |||
29339900 | LOPINAVIR >> LOPINAVIR | China | India | 15 | |||
29339900 | ORGANIC >> ORGANIC CHEMICAL SML1222-10MG LOPINAVIR [ORGANIC CHEMICAL] | United States | India | 2 | |||
29333990 | CHEMICAL >> ORGANIC CHEMICAL SML1222-50MG LOPINAVIR [ORGANIC CHEMICAL] | Germany | India | 1 | |||
29339900 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR SYSTEM SUITABILITY MIXTURE 20 MG -N | United States | India | NA | |||
38220090 | SYSTEM >> SYSTEM SUITABILITY Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS- 10MG PER VAIL 2 VAIL REFERENCE STANDARD FOR LABORATORY USE ONLY | France | India | NA | |||
29339900 | LOPINAVIR >> EP-Y0001498_LOPINAVIR 200 MG | France | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 6 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR 350 MG | United States | India | 1 | |||
38220090 | PHARMACEUTICAL >> PHARMACEUTICAL REFERENCE STANDARD - Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS 10 MG | France | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 4 | |||
29339900 | CHEMICAL >> ORGANIC CHEMICAL SML1222-50MG LOPINAVIR [ORGANIC CHEMICAL] | Germany | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 2 | |||
30049099 | HDPE >> KALETRA LOPINAVIR - RITONAVIR 200-50 MG TAB [HDPE-120]-ABBVIE | United States | India | 2 | |||
29335990 | SYSTEM >> SYSTEM SUITABILITY LOPINAVIR FOR SYSTEM SUITABILITY 3 NOS X 10 MG | France | India | 0.01 | |||
29335990 | PEAK >> LOPINAVIR FOR PEAK IDENTIFICATION 3 NOS X 10 MG | France | India | 0.01 | |||
30049099 | SIZE >> KALETRA LOPINAVIR AND RITONAVIR 200-50 MG TAB QTY.1 PACK , PACK SIZE.120S IN 1 BOTTLE | United States | India | 1 | |||
30049099 | RITONAVIR >> ALUVIA 200-50 MG LOPINAVIR & RITONAVIR | Germany | India | 2500 | |||
29335990 | LOPINAVIR >> USP-1370101_LOPINAVIR - 350 MG | United States | India | 1 | |||
30049099 | TABLETS >> KALETRA-LOPINAVIR AND RITONAVIR TABLET 200MG-50MG 8 BOTTLESX 120 TABLETS =960 TABLETS | United States | India | 0.24 | |||
29335990 | GRAMS >> 24761 LOPINAVIR REFERENCE STANDARD FOR VALUE FOR CUSTOM P - URPOSE ONLY 2 GRAMS | United States | India | 1 | |||
30049099 | TABLETS >> RITONAVIR TABLETS LOPINAVIR AND RITONAVIR TABLETS 200MG-50MG KALETRA 1 PACK X120 TABLETS = 120 TABLETS | Germany | India | 0.03 | |||
38229010 | 1370101 LOPINAVIR 350 MGCERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10 MGCERTIFIED REFERENCE STANDARDS | United States | India | 2 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10 MGCERTIFIED REFERENCE STANDARDS | United States | India | 3 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MGCERTIFIED REFERANCE STANDARDS | United States | India | 1 | |||
30049099 | lopinavir and ritonavir tablets 200 mg/50 mg 200/50 milligram mg KALETRA 2 PACKS X 120 TABLETS = 240 TABLETS | United States | India | 0.06 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
29339990 | LOPINAVIR AMORPHOUS USP RE-IMPORT VIDE SB.NO:4000577 DT:02.09.2020, SB NO:4000343 DT:10.06.2020 | Mexico | India | 297 | |||
29335999 | LOPINAVIR. | Mexico | India | 297.12 | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | 7 | |||
30049099 | KALETRA FILM-COATED TABLETS LOPINAVIR AND RITONAVIR FILM-COATED TABLETS 200MG/50MG 4 PACKS X 120 TABLETS =480 TABLETS | Malaysia | India | 0.12 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS-10mgCERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | 1370101 - LOPINAVIR 350 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | India | NA | |||
38229010 | 1370101 - LOPINAVIR 350 MG CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370101 LOPINAVIR 350 MG CERTIFIED REFERANCE STANDARDS | United States | India | 2 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001505-Lopinavir for system suitability CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506-Lopinavir for peak identification CRS 10MGCERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
38229010 | Y0001506 - LOPINAVIR FOR PEAK IDENTIFICATION CRS-10 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 2 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 2 | |||
38229010 | Y0001498 - LOPINAVIR CRS-170 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001498 - LOPINAVIR CRS-170 MG PER VIAL CERTIFIED REFERENCE STANDARDS | France | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRS10MGCERTIFIED REFERANCE STANDARDS | France | India | 3 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 1 | |||
38229010 | 1370156 - LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MG//R143T0/EAR90 CERTIFIED REFERENCE STANDARDS | United States | India | 5 | |||
38229010 | 1370101 - LOPINAVIR 350 MG/192725-17-0/R143S0/EAR99 CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 2 | |||
38229010 | Y0001505 LOPINAVIR FOR SYSTEM SUITABILITY CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 1 | |||
30049099 | Lopinavir and Ritonavir Tablets 100/25mg Kaletra 60 tablets qty 5 | United States | India | 5 | |||
29339990 | LOPINAVIR 350MG FOR TESTING PURPOSE | Belgium | India | 2 | |||
38229010 | Y0001506 LOPINAVIR FOR PEAK IDENTIFICATION CRSCERTIFIED REFERANCE STANDARDS10MG | France | India | 1 | |||
30049099 | Lopinavir and Ritonavir Tablets 200/50mg Kaletra 120 tablets qty 3 | United States | India | 3 | |||
38229010 | 1370101 - LOPINAVIR 350 MG/192725-17-0/R143S0/EAR99 CERTIFIED REFERENCE STANDARDS | United States | India | 1 | |||
38229010 | 1370156 - LOPINAVIR SYSTEM SUITABILITY MIXTURE 10MG//R143T0/EAR90 CERTIFIED REFERENCE STANDARDS | United States | India | 5 | |||
30049099 | LOPINAVIR AND RITONAVIR TABLETS 200MG/50MG 200/50 MILLIGRAMMGKALETRA 2 PACKS X 120 TABLETS = 240 TABLETS | United States | India | 0.20 | |||
98020000 | PHR1927-1G LOPINAVIR | United States | India | 1 | |||
98020000 | LOPINAVIR, L0377-1G LABORATORY CHEMICALS FOR R & D PURPOSE | China | India | 1 | |||
30049099 | LOPINAVIR AND RITONAVIR ORAL SOLUTION KALETRA 80/20 MILLIGRAM MG EACH BOTTLE 160 ML 4 BOTTLES | United States | India | 0.01 |
Volza's data of India Lopinavir imports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India Lopinavir imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India Lopinavir import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
You can find New markets for Lopinavir imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Major products related with Lopinavir are L Isoleucine, L Tyrosine, B Nad, Dl Phenylalanine, L Valine.
Top 5 HSN codes for Lopinavir are HSN Code 30049099 , HSN Code 29339900, HSN Code 29335990, HSN Code 38220090, HSN Code 38229010, You can check for details at https://www.volza.com/hs-codes.
Volza's data of India Lopinavir imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India Lopinavir imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Lopinavir, find economical vendors, new buyers and fast growing markets.
Data of India Lopinavir imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India Lopinavir imports every month.
As per the Volza's India import data of Lopinavir, United States accounted for maximum share with 196 shipments followed by France with 74 and Germany at 3rd spot with 74 shipments.
You can download latest data of Dec-2023 of India Lopinavir imports here
You can download Volza India Lopinavir import data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners